NCT04052360View on ClinicalTrials.gov

Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

November 2, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Cenerimod

A single oral dose of 4 mg cenerimod will be administered as a film-coated tablet in the morning of Day 1 under fasted conditions.

DRUG

Matching Placebo

A single oral dose of matching placebo will be administered as a film-coated tablet in the morning of Day 1 under fasted conditions.

Trial Locations (1)

92801

Anaheim Clinical Trials, Anaheim

All Listed Sponsors
lead

Viatris Innovation GmbH

INDUSTRY

NCT04052360 - Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects | Biotech Hunter | Biotech Hunter